| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). | Eur J Cancer | 1999 | 1.07 |
| 2 | Effects of impaired renal function on the pharmacokinetics and toxicity of i.v. ZD9331, a novel non-polyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors. | Anticancer Drugs | 2002 | 0.77 |
| 3 | Full ventricular capture indicated by the QT interval function. | Pacing Clin Electrophysiol | 1998 | 0.75 |
| 4 | Antimetabolites. | Cancer Chemother Biol Response Modif | 1994 | 0.75 |